Man K. Ho, Ph.D.
Affiliations: | 2011 | Pharmacology and Toxicology | University of Toronto, Toronto, ON, Canada |
Area:
Addiction, Drug MetabolismGoogle:
"Man Ho"Mean distance: 17.34 (cluster 19) | S | N | B | C | P |
Parents
Sign in to add mentorRachel F. Tyndale | grad student | 2011 | University of Toronto | |
(Impact of CYP2A6 genetic variation on nicotine metabolism and smoking behaviours in light smoking populations of Black-African descent.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Ho MK, Goldman D, Heinz A, et al. (2010) Breaking barriers in the genomics and pharmacogenetics of drug addiction. Clinical Pharmacology and Therapeutics. 88: 779-91 |
Ho MK, Faseru B, Choi WS, et al. (2009) Utility and relationships of biomarkers of smoking in African-American light smokers. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 18: 3426-34 |
Ho MK, Mwenifumbo JC, Al Koudsi N, et al. (2009) Association of nicotine metabolite ratio and CYP2A6 genotype with smoking cessation treatment in African-American light smokers. Clinical Pharmacology and Therapeutics. 85: 635-43 |
Mwenifumbo JC, Al Koudsi N, Ho MK, et al. (2008) Novel and established CYP2A6 alleles impair in vivo nicotine metabolism in a population of Black African descent. Human Mutation. 29: 679-88 |
Ho MK, Mwenifumbo JC, Zhao B, et al. (2008) A novel CYP2A6 allele, CYP2A6*23, impairs enzyme function in vitro and in vivo and decreases smoking in a population of Black-African descent. Pharmacogenetics and Genomics. 18: 67-75 |
Ho MK, Tyndale RF. (2007) Overview of the pharmacogenomics of cigarette smoking. The Pharmacogenomics Journal. 7: 81-98 |